Bacterium Manufacturing Protein 
Pharmaceutical Technology
MAY 18, 2023
An investigational orally delivered biologic drug, LMN-201 is a cocktail of four therapeutic proteins that act synergistically to neutralise the C difficile bacterium and the toxin. It is compatible with standard-of-care antibiotics.
XTalks
NOVEMBER 6, 2020
We are exceptionally pleased to commence dosing of our oral DNA vaccine for COVID-19 as we continue scale-up and manufacturing activities for future clinical development,” Symvivo’s chief medical officer Eric Sievers said in a press release from the company. Related: Red Meat Allergy Test Gets FDA Clearance. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MARCH 21, 2022
Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. The work solves a nearly 20-year riddle about how the marine bacterium makes the warhead that is unique to the salinosporamide molecule and opens the door to future biotechnology to manufacture new anti-cancer agents.
XTalks
NOVEMBER 10, 2020
The Canadian federal government has pledged $173 million in funding to Medicago for its vaccine research and development, as well as for the construction of its Quebec City manufacturing facility. Medicago has the added pressure of completing construction of a large-scale manufacturing facility in its home base of Quebec City.
XTalks
APRIL 17, 2023
It was caused by contaminated ice cream products manufactured by Blue Bell Creameries, a popular ice cream company based in Texas. The outbreak was caused by the bacterium Listeria monocytogenes , which was found in several samples of Blue Bell ice cream products, as well as in the company’s manufacturing facilities.
XTalks
AUGUST 2, 2023
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. Johnson & Johnson’s Top 5 Best-Selling Drugs of 2022: 1) Stelara (ustekinumab) Stelara is an immunosuppressant biologic therapy that blocks the IL-12 and IL-23 proteins that play a role in plaque psoriasis and Crohn’s disease.
The Pharma Data
JUNE 2, 2022
Affinivax’s most advanced vaccine candidate (AFX3772) includes 24 pneumococcal polysaccharides plus two conserved pneumococcal proteins (compared to up to 20 serotypes in currently approved vaccines). The bacterium Streptococcus pneumoniae causes pneumococcal disease. About Pneumococcal disease.
Expert insights. Personalized for you.
130 
Let's personalize your content